Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License

Tilray Medical has launched its first commercial German-grown medical cannabis products from its Aphria RX facility under a newly issued cultivation license. The company received Germany’s first medical cannabis cultivation license under MedCanG on July 15, 2024, allowing them to cultivate and manufacture a broad range of medical cannabis products. The strains selected for cultivation at the indoor facility are derived from top-performing varieties popular with patients in Canada. This development strengthens Tilray’s position in German medical cannabis cultivation, production, and distribution.